- Home
- NMRA
NMRA
Neumora Therapeutics Inc.
as 12-18-2024 3:37pm EST
Stocks
| Founded: | 2019 | Country: | United States |
| Employees: | N/A | City: | WATERTOWN |
| Market Cap: | N/A | IPO Year: | 2023 |
| Target Price: | $23.40 | AVG Volume (30 days): | 826.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.86 | EPS Growth: | N/A |
| 52 Week Low/High: | $8.33 - $21.00 | Next Earning Date: | 11-12-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Neumora Therapeutics Inc. (NMRA)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Fust Matthew K | NMRA | Director | Oct 17 '24 | Sell | $17.02 | 21,788 | $370,961.81 | 20,100 | |
| Lenz Robert A. | NMRA | Head of R&D | Oct 9 '24 | Sell | $15.05 | 13,823 | $208,110.23 | 322,966 |
Latest Neumora Therapeutics Inc. News
NMRA Breaking Stock News: Dive into NMRA Ticker-Specific Updates for Smart Investing
Insider Monkey
a month ago
Neumora Therapeutics, Inc. (NMRA): This Small-Cap Stock Is Ready To Explode
MT Newswires
a month ago
Neumora Therapeutics Q3 Loss Narrows
GlobeNewswire
a month ago
Neumora Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
a month ago
Neumora Therapeutics to Participate in Upcoming Conferences in November
MT Newswires
a month ago
JPMorgan Downgrades Neumora Therapeutics to Neutral, $15 Price Target
GlobeNewswire
2 months ago
Neumora Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
MT Newswires
2 months ago
Neumora Therapeutics Insider Sold Shares Worth $370,962, According to a Recent SEC Filing
Simply Wall St.
3 months ago
Neumora Therapeutics (NASDAQ:NMRA) Is In A Good Position To Deliver On Growth Plans
Compare NMRA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NMRA Neumora Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.